Works by HEBON

Results: 6
    1
    2

    Ovarian stimulation for IVF and risk of primary breast cancer in BRCA1/2 mutation carriers.

    Published in:
    2018
    By:
    • Derks-Smeets, Inge A. P.;
    • Schrijver, Lieske H.;
    • de Die-Smulders, Christine E. M.;
    • Tjan-Heijnen, Vivianne C. G.;
    • van Golde, Ron J. T.;
    • Smits, Luc J.;
    • Caanen, Beppy;
    • van Asperen, Christi J.;
    • Ausems, Margreet;
    • Collée, Margriet;
    • van Engelen, Klaartje;
    • Kets, C. Marleen;
    • van der Kolk, Lizet;
    • Oosterwijk, Jan C.;
    • van Os, Theo A. M.;
    • HEBON;
    • Rookus, Matti A.;
    • van Leeuwen, Flora E.;
    • Gómez García, Encarna B.
    Publication type:
    journal article
    3

    Improved overall survival after contralateral risk-reducing mastectomy in BRCA1/2 mutation carriers with a history of unilateral breast cancer: A prospective analysis.

    Published in:
    International Journal of Cancer, 2015, v. 136, n. 3, p. 668, doi. 10.1002/ijc.29032
    By:
    • Heemskerk‐Gerritsen, Bernadette A.M.;
    • Rookus, Matti A.;
    • Aalfs, Cora M.;
    • Ausems, Margreet G.E.M.;
    • Collée, Johanna M.;
    • Jansen, Liesbeth;
    • Kets, C. Marleen;
    • Keymeulen, Kristien B.M.I.;
    • Koppert, Linetta B.;
    • Meijers‐Heijboer, Hanne E.J.;
    • Mooij, Thea M.;
    • Tollenaar, Rob A.E.M.;
    • Vasen, Hans F.A.;
    • HEBON;
    • Hooning, Maartje J.;
    • Seynaeve, Caroline
    Publication type:
    Article
    4

    High-grade serous carcinoma occurring after risk-reducing salpingo-oophorectomy in BRCA1/2 germline pathogenic variant carriers.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2025, v. 117, n. 4, p. 719, doi. 10.1093/jnci/djae300
    By:
    • Stroot, Iris A S;
    • Bart, Joost;
    • Hollema, Harry;
    • Wagner, Marise M;
    • Yigit, Refika;
    • Doorn, Helena C van;
    • Hullu, Joanne A de;
    • Gaarenstroom, Katja N;
    • Beurden, Marc van;
    • Lonkhuijzen, Luc R C W van;
    • Slangen, Brigitte F M;
    • Zweemer, Ronald P;
    • Garcia, Encarna B Gómez;
    • Ausems, Margreet G E M;
    • Komdeur, Fenne L;
    • Asperen, Christi J van;
    • Adank, Muriel A;
    • Wevers, Marijke R;
    • Hooning, Maartje J;
    • Investigators, HEBON
    Publication type:
    Article
    5

    Contralateral breast cancer risk in patients with breast cancer and a germline-BRCA1/2 pathogenic variant undergoing radiation.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 11, p. 1318, doi. 10.1093/jnci/djad116
    By:
    • Barele, Mark van;
    • Akdeniz, Delal;
    • Heemskerk-Gerritsen, Bernadette A M;
    • Genepso;
    • Andrieu, Nadine;
    • Noguès, Catherine;
    • HEBON;
    • Asperen, Christi J van;
    • Wevers, Marijke;
    • Ausems, Margreet G E M;
    • Bock, Geertruida H de;
    • Dommering, Charlotte J;
    • Gómez-García, Encarnacion B;
    • Leeuwen, Flora E van;
    • Mooij, Thea M;
    • EMBRACE;
    • Easton, Douglas F;
    • Antoniou, Antonis C;
    • Evans, D Gareth;
    • Izatt, Louise
    Publication type:
    Article
    6

    Endometrial Cancer Risk in Women With Germline BRCA1 or BRCA2 Mutations: Multicenter Cohort Study.

    Published in:
    2021
    By:
    • Jonge, Marthe M de;
    • Kroon, Cornelis D de;
    • Jenner, Denise J;
    • Oosting, Jan;
    • Hullu, Joanne A de;
    • Mourits, Marian J E;
    • Garcia, Encarna B Gómez;
    • Ausems, Margreet G E M;
    • Collée, J Margriet;
    • Engelen, Klaartje van;
    • van de Beek, Irma;
    • Group, The Hebon;
    • Smit, Vincent T H B M;
    • Rookus, Matti A;
    • Bock, Geertruida H de;
    • Leeuwen, Flora E van;
    • Bosse, Tjalling;
    • Dekkers, Olaf M;
    • Asperen, Christi J van;
    • de Jonge, Marthe M
    Publication type:
    journal article